Appointment sheet
Invasive breast carcinoma of no special type (invasive ductal carcinoma)
Prepared with OnCo (onco.cc/prep/invasive-breast-carcinoma-no-special-type/). Orientation, not medical advice; your team knows your case.
My details
Name
Date of appointment
Hospital and clinician
Who is coming with me
What I know, what is unclear, changes to discuss
Saved in this browserWhat I know so far
What is unclear to me
Changes since last time
My questions
8 on the sheetNewly diagnosed
- 1.What is my exact diagnosis, stage, and grade, and which tests established them?
- 2.Which biomarkers have been tested on my tumour (for example Oestrogen receptor, progesterone receptor and HER2, Nottingham grade, Ki-67 and genomic assaysin early HR-positive disease), and what were the results?
- 3.Which subtype is my cancer, and does that change the recommended treatment?
- 4.Is germline (inherited) genetic testing recommended for me or my family?
All stages
- 5.For my situation (all stages), which of the standard options do you recommend and why?
- 6.Am I a candidate for Oncotype DX, and what side effects should I expect?
Any stage
- 7.Would a second opinion at a high-volume centre change anything, and can you help arrange it?
- 8.What supportive care (symptom control, nutrition, exercise, mental health, financial help) is available from the start?
Tests and results to bring
Biomarker results to ask for: Oestrogen receptor, progesterone receptor and HER2, Nottingham grade, Ki-67 and genomic assays (Oncotype DX and others) in early HR-positive disease.
Scans and tests linked to this cancer: Companion diagnostics, RNA sequencing & expression profiling, Gene-expression prognostic assays.
Bring copies of scan reports, pathology and blood results, and a list of every medicine and supplement.
The treatments I may be offered
- All stages: Treated as the parent's receptor pages describe. (Breast cancer (all types), HR-positive / HER2-negative breast cancer, HER2-positive breast cancer, Triple-negative breast cancer (TNBC), Oncotype DX)
From the standard of care recorded for this cancer; which apply depends on your stage and biomarkers. Ask which the team recommends and why.
Answers and next steps
Saved in this browserWhat I was told
Agreed next steps, dates and who to call